Several studies evaluated the effect of anti-CTLA-4 and anti-PD-1 monoclonal antibodies in CM patients [2, 9–11, 26], but results of ICI in patients with UM have been disappointing. This evidence concerns the gene CTLA4 and cutaneous mastocytosis.